Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Usher Syndrome Type 3a. Data from NIH RePORTER, last 36 months.
Usher Syndrome Type 3a has emerging NIH research funding with 2 grants totaling $713K.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Usher Syndrome Type 3a. Strongest funded area: Gene Therapy / Cell Therapy. Largest gap: Gene Therapy / Cell Therapy.
1 clinical trial registered but no NIH-funded clinical or translational research grants found for Usher syndrome type 3A. Trials may be industry-sponsored or funded through non-NIH sources.
2 funded grants in Gene Therapy / Cell Therapy but only 0 related publications found for Usher syndrome type 3A. This may indicate early-stage research that hasn't yet produced published results.